According to Heska Corporation 's latest financial reports the company's current EPS (TTM) is -$1.93. In 2022 the company made an earnings per share (EPS) of -$1.93 a decrease over its 2021 EPS that were of -$0.10000.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.93 | -0% |
2022 | -$1.93 | 1830% |
2021 | -$0.10000 | -94.19% |
2020 | -$1.72 | 805.26% |
2019 | -$0.19 | -123.75% |
2018 | $0.80 | -43.26% |
2017 | $1.41 | -9.03% |
2016 | $1.55 | 93.75% |
2015 | $0.80 | 81.82% |
2014 | $0.44 | -309.52% |
2013 | -$0.21 | -195.45% |
2012 | $0.22 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Novartis NVS | $3.74 | -293.78% | ๐จ๐ญ Switzerland |
Pfizer PFE | $1.86 | -196.37% | ๐บ๐ธ USA |
Eli Lilly LLY | $5.43 | -381.31% | ๐บ๐ธ USA |
IDEXX Laboratories IDXX | $9.91 | -613.47% | ๐บ๐ธ USA |
Zoetis ZTS | $4.92 | -354.92% | ๐บ๐ธ USA |
Merck MRK | $1.82 | -194.39% | ๐บ๐ธ USA |
Petco WOOF | $0.13 | -106.74% | ๐บ๐ธ USA |